What is B-Secur?
B-Secur is dedicated to enhancing heart health through its proprietary HeartKey solutions, which are designed to revolutionize EKG interpretation by providing superior data and actionable insights. Their flagship product, HeartKey Rhythm, is an FDA-cleared universal ECG analytics software that delivers precise rhythm detection and analysis for comprehensive cardiac monitoring. The company's strategic objective is to achieve high clinical accuracy and operational efficiencies within the cardiac care sector, serving healthcare providers and medical professionals. B-Secur's technology is engineered for versatility, operating seamlessly on both cloud and device platforms to ensure widespread accessibility and effectiveness in monitoring heart health.
How much funding has B-Secur raised?
B-Secur has raised a total of $25.7M across 4 funding rounds:
Other Financing Round
$3.9M
Angel/Seed
$4.6M
Unspecified
$5.3M
Other Financing Round
$12M
Other Financing Round (2015): $3.9M with participation from Rudolf Wolff
Angel/Seed (2017): $4.6M led by British Business Bank, Woodford Investment Management, Accelerated Digital Ventures, and Kernel Capital
Unspecified (2019): $5.3M supported by Kernel Capital and Accelerated Digital Ventures
Other Financing Round (2021): $12M featuring First Capital Ventures
Key Investors in B-Secur
Kernel Capital
Kernel Capital is a venture capital and private equity firm specializing in investing in growth and early-stage companies, providing both capital and strategic guidance to foster scaling and successful exits. They primarily serve technology and innovation-driven businesses.
Accelerated Digital Ventures
Accelerated Digital Ventures Ltd is a company operating in the Custom Software & IT Services industry, headquartered in Newcastle upon Tyne, United Kingdom. They focus on supporting digital ventures.
First Capital Ventures
First Capital Ventures, Inc. is an investment group focused on healthcare and related technologies, including digital health and wellness. They leverage a network of accredited investors to support innovation-driven companies.
What's next for B-Secur?
With the recent infusion of major strategic investment, B-Secur is poised for accelerated growth and market expansion. The enterprise-level funding suggests a transition into a scaling phase, likely enabling the company to enhance its technological capabilities, broaden its product offerings, and strengthen its market presence. Future developments may include further clinical validation, strategic partnerships with healthcare systems, and the integration of advanced AI for predictive cardiac analytics. This capital injection is expected to solidify B-Secur's position as a leader in digital health and cardiac monitoring innovation.
See full B-Secur company page
